SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-19-006728
Filing Date
2019-05-14
Accepted
2019-05-14 16:04:52
Documents
9
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 6-K auph-0331196xk.htm 6-K 17945
2 EXHIBIT 99.1 exhibit991-20190331interim.htm EX-99.1 569756
3 EXHIBIT 99.2 exhibit992-20190331mda.htm EX-99.2 355376
4 EXHIBIT 99.3 exhibit993-20190331certifi.htm EX-99.3 15869
5 EXHIBIT 99.4 exhibit994-20190331certifi.htm EX-99.4 15744
6 aurinialogoa05.jpg GRAPHIC 15156
7 aurinialogoweb700pxa04.jpg GRAPHIC 77311
8 fscover.jpg GRAPHIC 43269
9 mdacover.jpg GRAPHIC 46173
  Complete submission text file 0001628280-19-006728.txt   1210133
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 19822670
SIC: 2834 Pharmaceutical Preparations